Cannabidiol and it fluorinate analog PECS-101 reduces hyperalgesia and allodynia in trigeminal neuralgia via TRPV1 receptors

Cannabidiol and it fluorinate analog PECS-101 reduces hyperalgesia and allodynia in trigeminal neuralgia via TRPV1 receptors

Authors: Daniela Maria Escobar-Espinal a, Airam Nicole Vivanco-Estela a, Núbia Barros b, Maurício dos Santos Pereira a, Francisco Silveira Guimaraes b, Elaine Del Bel a c d, Glauce C. Nascimento a
Publication: Progress in Neuro-Psychopharmacology and Biological Psychiatry
Year: 2024
View Article

The Facial Pain Research Foundation, Inc
2653 SW 87th Drive Suite A
Gainesville FL 32608-9313

Mailing address for Donations and all other correspondences:
4591 W. Higgins Road, Suite 703
Hoffman Estates, IL 60192

info@facingfacialpain.org

Nonprofit 501(c)3 Tax exempt organization. Gifts are tax deductible to the amount allowed by law. EIN 82-1317992

Get Updates On Our Research!

By submitting this form, you are consenting to receive marketing emails from: The Facial Pain Research Foundation. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact
Go to Top